Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals)
Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others)
Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, Other Antivirals)
The report covers both currently marketed and late stage development products. Revenues for each segment were generated using dollar and unit sales for each product.
A novel approach in this report is that it provides revenue by product type but also the 'market' for treatments by type of infection, enabling marketers to research the best markets where a variety of products may be implemented.
The report includes statistical information for infections by type worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers.